German Federal Minister of Economic Cooperation and Development Tours Vetter |
| Print | |
| Monday, 14 February 2011 20:00 (UTC + 1) |
|
Dirk Niebel cites “noteworthy contribution to the development of the global pharmaceutical market”
Ravensburg, Germany, February 14, 2011 / b3c newswire / – Dirk Niebel, Germany’s Federal Minister for Economic Cooperation and Development, stopped today at Vetter’s Ravensburg Vetter South facility during a regional tour. Vetter is an independent international specialist in the aseptic filling of drug-delivery systems. "Innovative, mid-sized companies like Vetter are not only an important engine of the German economy," said Niebel, “but as successful international players, they make a noteworthy contribution to the development of the global pharmaceutical market."
Vetter, whose staff numbers 2,300 in "We are pleased to receive a high-level visit from Germany´s capital," said Udo J. Vetter, partner and chairman of the company’s advisory board. "We have grown steadily since our founding and are among the leading providers in our segment. A visit by Federal Minister Niebel underscores that a family-run mid-sized company can be a successful global player."
Udo J. Vetter, partner and chairman of Vetter’s advisory board (fourth from right), greets For a high resolution picture please right-click the image and select "Save Target As..." Federal Minister Dirk Niebel during his speech at Ravensburg Vetter South, Vetter’s most advanced production facility, used to manufacture biologic drugs. For a high resolution picture please right-click the image and select "Save Target As..." Federal Minister Dirk Niebel (second from left) during his tour through the Ravensburg Vetter South manufacturing facility. Udo J. Vetter, partner and chairman of Vetter’s advisory board (far left) describes the aseptic filling process.
About Vetter - www.vetter-pharma.com Vetter is an independent international specialist in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with a broad array of substances, including monoclonal antibodies, peptides, interferons and vaccines. Headquartered in
Vetter Pharma International GmbH Oskar Gold Eywiesenstrasse 5 88212 Ravensburg phone: +49-(0)751-3700-3729 fax: +49-(0)751-3700-7707 e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it |



